Skip to main content

Table 3 Peptide concentrations per group (fmol.μg-total-protein−1)

From: Personalised modelling of clinical heterogeneity between medium-chain acyl-CoA dehydrogenase patients

Peptide

Asymptomatic

All subjects

(n = 14)

All MCADD

(n = 10)

Mean

(95% confidence intervals, based on t distribution)

CPT2

0.21

0.19

(0.09–0.29)

0.19

(0.10–0.28)

VLCAD

1.60

1.33

(0.30–2.36)

1.41

(0.44–2.38)

MCAD

0.23

0.52

(-0.65–1.68)

0.18

(0.06–0.29)

SCAD

0.38

0.21

(0.06–0.37)

0.21

(0.04–0.38)

ETFa

0.36

0.32

(0.14–0.50)

0.34

(0.13–0.54)

ETFb

1.03

1.09

(0.37–1.81)

1.12

(0.37–1.81)

MCKAT

2.84

2.68

(0.53–4.83)

2.71

(0.58–4.83)

HADHa

1.80

1.34

(0.57–2.10)

1.41

(0.64–2.17)

HADHb

1.80

1.26

(0.35–2.18)

1.29

(0.39–2.20)